Photobiomodulation (PBM) for radiodermatitis in patients with head and neck cancer (HNC) undergoing radiotherapy: A large real-world cohort and benchmarking against historical data.
365 Background: Radiation dermatitis is nearly universal among patients with HNC receiving radiotherapy, with 73-80% developing grade ≥2 and 14-25% developing grade ≥3 toxicity in contemporary trials. Recovery typically occurs 2-4 weeks after treatment ends, with complete resolution by 6-8 weeks. PBM has demons...